NFCA Webinars are geared for those with celiac disease and other gluten-related disorders as well as the dietitians and providers who serve them. Thanks to the support of sponsors, these Webinars continue to be free of charge!
If you have a Webinar idea or topic you'd like to see discussed, please contact email@example.com.
Note: A recording of each Webinar will be posted along with the Webinar slides within 72 hours after the live Webinar ends. To download recorded Webinars and slides, visit the Archived Webinars page.
Click here to see the 2015 webinar schedule.
Webinar Special! The Future of Drug Therapies for Celiac Disease:
Get the Honest Facts
Tuesday, March 31, 2015
7 p.m. to 8 p.m. EST/4 p.m. to 5 p.m. PST
The field of celiac disease research is moving rapidly, and some of the most exciting developments have been in the area of pharmaceutical therapies. Here at NFCA, we regularly talk to the community about their interest in a drug to treat celiac disease, and we hear your feelings of hesitancy and worry about the implications of a new treatment for the genetic autoimmune disease. Today, it’s time to open an honest conversation about the future of celiac disease treatment and management.
Join us for a special webinar event on Tuesday, March 31, 2015 at 7 p.m. EDT/4 p.m. PDT as we speak with celiac disease experts and NFCA Scientific/Medical Advisory Council members Sheila Crowe, MD, UC San Diego, School of Medicine and Vice President of the American Gastroenterological Association (AGA) and Ritu Verma, MD, Director of the Center for Celiac Disease and the Lustgarten Endowed Chair for Clinical Care of GI Motility Disorders at The Children's Hospital of Philadelphia. Alice Bast, President and CEO of NFCA, and Marilyn Geller, CEO of the Celiac Disease Foundation, will also join the discussion representing the voice of the patient and the caregiver, respectively.
This free webinar will be moderated by NFCA Director of Healthcare Initiatives Kristin Voorhees, MA, and will be airing after the GREAT 3 Workshop, a landmark event being hosted by the U.S. Food and Drug Administration (FDA). Learn more about GREAT 3 here.
This Webinar is free of charge and the only requirement is a working internet connection!
About the Panelists
Alice Bast, President and CEO, National Foundation for Celiac Awareness
As founder, president, and CEO of the National Foundation for Celiac Awareness (NFCA), Alice Bast is widely regarded as a celiac disease expert and has been a keynote speaker at major medical and allied health industry events, plus culinary and foodservice industry conferences.
NFCA works to ensure that celiac disease can be promptly diagnosed and effectively managed. Through education and empowerment, NFCA enables the community to make the best decisions that reflect their desired health outcomes. NFCA serves as a leading free resource for people with celiac disease and their families and is also a leader in providing accredited training for food industry professionals. By inspiring hope and accelerating innovation, NFCA serves those on a lifelong gluten-free diet and forges pathways to a cure. Read more about Alice Bast here.
Sheila E. Crowe, M.D.
Sheila E. Crowe, M.D., is a professor of medicine and director of research in the Division of Gastroenterology at UC San Diego School of Medicine. She is also the director of the Celiac Disease Clinic at UC San Diego Health System. Dr. Crowe is a member of NFCA’s Scientific/Medical Advisory Council and is Councilor-at-Large for the North American Society for the Study of Celiac Disease (NASSCD).
Marilyn G. Geller, Chief Executive Office, Celiac Disease Foundation
Marilyn G. Geller is Chief Executive Officer for Celiac Disease Foundation (CDF). Her organization drives diagnosis and treatment of celiac disease through advocacy, education and advancing research to improve the quality of life for all people with gluten-related disorders. As the mother of a son with celiac disease, undiagnosed until the age of 15 despite lifelong symptoms, Marilyn is a determined advocate for celiac disease and gluten sensitivity advocacy, education and research.
Ritu Verma, M.D.
Ritu Verma, M.D., is the Director of the Center for Celiac Disease and the Lustgarten Endowed Chair for Clinical Care of GI Motility Disorders at The Children’s Hospital of Philadelphia. She is also the Section Chief of Clinical Gastroenterology and an Associate Professor of Clinical Pediatrics at the Perelman School of Medicine at the University of Pennsylvania. Serving on NFCA’s Scientific/Medical Advisory Council, Dr. Verma is a leading and trusted expert in the field.